Fitzbio Research HubEducational content only — not medical advice

Mitochondrial research

SS-31 (Elamipretide)

A mitochondria-targeting peptide studied in clinical and preclinical energy research.

28 connected records28 graded citations0 external identifiers

Research context

A mitochondria-targeting peptide studied in clinical and preclinical energy research.

Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.

Evidence map

Claims linked to original records.

Evidence levels describe study design. They do not by themselves establish safety or effectiveness.

Not yet classified

Patel PS, Pabla NS, Bajwa A

Therapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury.

pubmed 2026
Not yet classified

Ciszewski P, Drelichowska A, Pikor D, Wiśniewska E, Azierski M

Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future.

pubmed
Not yet classified

Nashine S

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).

pubmed
Clinical trial

To evaluate the safety, tolerability, and activity of Elamipretide in treating vision loss in Friedreich Ataxia (FRDA).

FRDA Investigator Initiated Study (IIS) With Elamipretide

clinicaltrials 2021
Not yet classified

Xiao D, Cui X, Ali S, Li C, Wang B · Physiological research

Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress.

pmc
Not yet classified

Xie L, Wu J, Fan J, Krager KJ, Aykin-Burns N, Li S, Børsheim E, Qi X, Boerma M, Zhang H · Journal of radiation research

Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence.

pmc
Not yet classified

Fan J, Wu J, Yan S, Li S, Rabinovitch PS, Qi X, Zhang H · Biology

Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence.

pmc
Not yet classified

Patai R, Patel K, Csik B, Gulej R, Nagaraja RY, Nagy D, Chandragiri SS, Shanmugarama S, Kordestan KV, Nagykaldi M, Ekambaram S, Ungvari A, Yabluchanskiy A, Tarantini S, Benyo Z, Csiszar A, Ungvari Z, Nyul-Toth A · GeroScience

Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.

pmc 2025
Not yet classified

Romanova N, Sule K, Issler T, Hebrok D, Persicke M, Thévenod F, Prenner EJ, Lee WK · Journal of lipid research

Cadmium-cardiolipin disruption of respirasome assembly and redox balance through mitochondrial membrane rigidification.

pmc 2025
Not yet classified

Mitchell W, Tamucci JD, Ng EL, Liu S, Birk AV, Szeto HH, May ER, Alexandrescu AT, Alder NN · eLife

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.

pmc
Not yet classified

Nashine S · Cells

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).

pmc
Not yet classified

Zhang H, Alder N, Wang W, Szeto H, Marcinek D, Rabinovitch P · Innovation in Aging

Reduction of Elevated Proton Leak Rejuvenates Mitochondria in the Aged Cardiomyocyte.

pmc 2026
Not yet classified

Zengtao Song, Zhaoliang Ban, Haosen Zhao, Xifan Mei · Elsevier BV

Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury

crossref 2026
Not yet classified

Background: It is widely accepted that mitochondria have a direct impact on neuronal function and survival. Oxidative stress caused by mitochondrial abnormalities play an important role in the pathophysiology of lipopolysaccharide (LPS)-induced memory impairment. Elamipretide (SS-31) is a novel mitochondrion-targeted antioxidant. However, the impact of...

Elamipretide (SS-31) Improves Mitochondrial Dysfunction, Synaptic and Memory Impairment Induced by Lipopolysaccharide in Mice

crossref 2019
Not yet classified

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a major cause of cirrhosis, liver cancer, and cardiovascular disease. Early mitochondrial dysfunction drives lipid imbalance, inflammation, and fibrosis. Given the lack of approved pharmacological treatments, this study compares the mitochondria-targeted agents MitoQ and SS-31 for their effects...

Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress

crossref 2026
Not yet classified

Modern bioactive agents, including incretin receptor agonists, mitochondria-targeting peptides, growth hormone–releasing hormone analogues, and melanocortin receptor agonists, have substantially reshaped therapeutic strategies across metabolic disorders, HIV-associated lipodystrophy, hypoactive sexual desire disorder, and primary mitochondrial diseases. Tirzepatide has demonstrated significant efficacy in glycemic control and weight...

<b>TIRZEPATIDE, ELAMIPRETIDE (SS-31), TESAMORELIN AND BREMELANOTIDE: MECHANISTIC FOUNDATIONS, CLINICAL EVIDENCE AND THERAPEUTIC APPLICATIONS IN METABOLIC, MITOCHONDRIAL AND NEUROENDOCRINE CONTEXTS</b>

crossref 2026
Not yet classified

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal lung disease with a limited therapeutic strategy. Mitochondrial oxidative stress in macrophages is directly linked to IPF. Elamipretide(SS-31) is a mitochondrion-targeted peptide that has been shown to be safe and beneficial for multiple diseases. However, whether SS-31...

Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages

crossref 2023
Not yet classified

Nathan N. Alder, Wayne Mitchell, Emily Ng, Kevin Boyd, Jeffrey Tamucci, Eric May, Nicholas Eddy, Hazel Szeto · Elsevier BV

Biophysical Approaches Toward Understanding the Molecular Mechanism of Action of the Mitochondrial Therapeutic SS-31 (Elamipretide)

crossref 2019
Not yet classified

Qinghuan Yang, Yiyao Zhang, Pingping Liu, Zhiwen Yan, Changqing Li, Yinghong Tang, Qin Yang · Springer Science and Business Media LLC

Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice

crossref 2026
Not yet classified

Josie A. Silvaroli, Bijay Bisunke, Ji Young Kim, Navjot Singh P. Pabla, Amandeep Bajwa · Ovid Technologies (Wolters Kluwer Health)

Genome-Wide CRISPR Screen Reveals That Elamipretide (SS-31) Mediated PLSCR3 Activation Mitigates Mitochondrial Dysfunction During AKI

crossref 2022
Not yet classified

Weixing Zhao, Zhipeng Xu, Jiangbei Cao, Qiang Fu, Yishuang Wu, Xiaoying Zhang et al. · Journal of Neuroinflammation · 212 citations

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice

openalex 2019
Not yet classified

Roland Patai, Krish Patel, Boglárka Csík, Rafał Gulej, Raghavendra Yelahanka Nagaraja, Dorina Nagy et al. · GeroScience · 15 citations

Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening

openalex 2025
Not yet classified

Wayne A. Mitchell, Emily A. Ng, Jeffrey D. Tamucci, Kevin J. Boyd, Murugappan Sathappa, Adrian Coscia et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7 citations

Molecular Mechanism of Action of Mitochondrial Therapeutic SS-31 (Elamipretide): Membrane Interactions and Effects on Surface Electrostatics

openalex 2019
Not yet classified

Jing Wu, Shuangying Hao, Xiaoru Sun, Hui Zhang, Huihui Li, Hongting Zhao et al. · Frontiers in Cellular Neuroscience · 44 citations

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats

openalex 2017
Not yet classified

Jeremy D. Whitson, Miguel Martín‐Pérez, Tong Zhang, Matthew J. Gaffrey, Gennifer E. Merrihew, Eric L. Huang et al. · GeroScience · 34 citations

Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins

openalex 2021
Not yet classified

Yunjuan Nie, Jiao Li, Xiaorun Zhai, Zhixu Wang, Junpeng Wang, Yaxian Wu et al. · Antioxidants · 23 citations

Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages

openalex 2023
Not yet classified

Yang Liu, Huiqun Fu, Yan Wu, Binbin Nie, Fangyan Liu, Tianlong Wang et al. · Frontiers in Aging Neuroscience · 30 citations

Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats

openalex 2021
Not yet classified

Matthew D. Campbell, Jicheng Duan, Ashton T. Samuelson, Matthew J. Gaffrey, Gennifer E. Merrihew, Jarrett D. Egertson et al. · Free Radical Biology and Medicine · 144 citations

Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice

openalex 2018

Connected data hub

Records with source provenance.

Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.

Open Access Article

8 records
pmcAutomated import

Reduction of Elevated Proton Leak Rejuvenates Mitochondria in the Aged Cardiomyocyte.

Zhang H, Alder N, Wang W, Szeto H, Marcinek D, Rabinovitch P · Innovation in Aging

PMC77436952026-09-27
pmcAutomated import

Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.

Patai R, Patel K, Csik B, Gulej R, Nagaraja RY, Nagy D, Chandragiri SS, Shanmugarama S, Kordestan KV, Nagykaldi M, Ekambaram S, Ungvari A, Yabluchanskiy A, Tarantini S, Benyo Z, Csiszar A, Ungvari Z, Nyul-Toth A · GeroScience

PMC121816152025-06-01
pmcAutomated import

Cadmium-cardiolipin disruption of respirasome assembly and redox balance through mitochondrial membrane rigidification.

Romanova N, Sule K, Issler T, Hebrok D, Persicke M, Thévenod F, Prenner EJ, Lee WK · Journal of lipid research

PMC119058372025-03-01
pmcAutomated import

Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress.

Xiao D, Cui X, Ali S, Li C, Wang B · Physiological research

PMC1358066927 Sep 2026
pmcAutomated import

Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence.

Xie L, Wu J, Fan J, Krager KJ, Aykin-Burns N, Li S, Børsheim E, Qi X, Boerma M, Zhang H · Journal of radiation research

PMC1340057127 Sep 2026
pmcAutomated import

Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence.

Fan J, Wu J, Yan S, Li S, Rabinovitch PS, Qi X, Zhang H · Biology

PMC1335991227 Sep 2026
pmcAutomated import

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.

Mitchell W, Tamucci JD, Ng EL, Liu S, Birk AV, Szeto HH, May ER, Alexandrescu AT, Alder NN · eLife

PMC934295727 Sep 2026
pmcAutomated import

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).

Nashine S · Cells

PMC846498827 Sep 2026

Scholarly Work

8 records
crossrefAutomated import

Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a major cause of cirrhosis, liver cancer, and cardiovascular disease. Early mitochondrial dysfunction drives lipid imbalance, inflammation, and fibrosis. Given the lack of approved pharmacological treatments, this study compares the mitochondria-targeted...

10.33549/physiolres.9358102026-08-31
crossrefAutomated import

Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice

Qinghuan Yang, Yiyao Zhang, Pingping Liu, Zhiwen Yan, Changqing Li, Yinghong Tang, Qin Yang · Springer Science and Business Media LLC

10.1007/s11064-026-04846-z2026-07-14
crossrefAutomated import

Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury

Zengtao Song, Zhaoliang Ban, Haosen Zhao, Xifan Mei · Elsevier BV

10.1016/j.neuint.2026.1061712026-07-01
crossrefAutomated import

<b>TIRZEPATIDE, ELAMIPRETIDE (SS-31), TESAMORELIN AND BREMELANOTIDE: MECHANISTIC FOUNDATIONS, CLINICAL EVIDENCE AND THERAPEUTIC APPLICATIONS IN METABOLIC, MITOCHONDRIAL AND NEUROENDOCRINE CONTEXTS</b>

Modern bioactive agents, including incretin receptor agonists, mitochondria-targeting peptides, growth hormone–releasing hormone analogues, and melanocortin receptor agonists, have substantially reshaped therapeutic strategies across metabolic disorders, HIV-associated lipodystrophy, hypoactive sexual desire disorder, and primary mitochondrial diseases. Tirzepatide has demonstrated...

10.65671/g269y6062026-02-25
crossrefAutomated import

Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal lung disease with a limited therapeutic strategy. Mitochondrial oxidative stress in macrophages is directly linked to IPF. Elamipretide(SS-31) is a mitochondrion-targeted peptide that has been shown to be safe and...

10.3390/antiox121220222023-11-21
crossrefAutomated import

Genome-Wide CRISPR Screen Reveals That Elamipretide (SS-31) Mediated PLSCR3 Activation Mitigates Mitochondrial Dysfunction During AKI

Josie A. Silvaroli, Bijay Bisunke, Ji Young Kim, Navjot Singh P. Pabla, Amandeep Bajwa · Ovid Technologies (Wolters Kluwer Health)

10.1681/asn.20223311s114b2022-11-01
crossrefAutomated import

Biophysical Approaches Toward Understanding the Molecular Mechanism of Action of the Mitochondrial Therapeutic SS-31 (Elamipretide)

Nathan N. Alder, Wayne Mitchell, Emily Ng, Kevin Boyd, Jeffrey Tamucci, Eric May, Nicholas Eddy, Hazel Szeto · Elsevier BV

10.1016/j.bpj.2018.11.27592019-02-01
crossrefAutomated import

Elamipretide (SS-31) Improves Mitochondrial Dysfunction, Synaptic and Memory Impairment Induced by Lipopolysaccharide in Mice

Background: It is widely accepted that mitochondria have a direct impact on neuronal function and survival. Oxidative stress caused by mitochondrial abnormalities play an important role in the pathophysiology of lipopolysaccharide (LPS)-induced memory impairment. Elamipretide (SS-31) is a...

10.2139/ssrn.34110382019-01-01

Publication

3 records
pubmedAutomated import

Therapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury.

Patel PS, Pabla NS, Bajwa A

410277992026-01-01
pubmedAutomated import

Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future.

Ciszewski P, Drelichowska A, Pikor D, Wiśniewska E, Azierski M

4033096727 Sep 2026
pubmedAutomated import

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).

Nashine S

3457213127 Sep 2026

Article

7 records
openalexAutomated import

Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening

Roland Patai, Krish Patel, Boglárka Csík, Rafał Gulej, Raghavendra Yelahanka Nagaraja, Dorina Nagy et al. · GeroScience · 15 citations

10.1007/s11357-025-01634-52025-04-02
openalexAutomated import

Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages

Yunjuan Nie, Jiao Li, Xiaorun Zhai, Zhixu Wang, Junpeng Wang, Yaxian Wu et al. · Antioxidants · 23 citations

10.3390/antiox121220222023-11-21
openalexAutomated import

Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins

Jeremy D. Whitson, Miguel Martín‐Pérez, Tong Zhang, Matthew J. Gaffrey, Gennifer E. Merrihew, Eric L. Huang et al. · GeroScience · 34 citations

10.1007/s11357-021-00447-62021-09-04
openalexAutomated import

Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats

Yang Liu, Huiqun Fu, Yan Wu, Binbin Nie, Fangyan Liu, Tianlong Wang et al. · Frontiers in Aging Neuroscience · 30 citations

10.3389/fnagi.2021.6004842021-03-01
openalexAutomated import

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice

Weixing Zhao, Zhipeng Xu, Jiangbei Cao, Qiang Fu, Yishuang Wu, Xiaoying Zhang et al. · Journal of Neuroinflammation · 212 citations

10.1186/s12974-019-1627-92019-11-20
openalexAutomated import

Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice

Matthew D. Campbell, Jicheng Duan, Ashton T. Samuelson, Matthew J. Gaffrey, Gennifer E. Merrihew, Jarrett D. Egertson et al. · Free Radical Biology and Medicine · 144 citations

10.1016/j.freeradbiomed.2018.12.0312018-12-28
openalexAutomated import

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats

Jing Wu, Shuangying Hao, Xiaoru Sun, Hui Zhang, Huihui Li, Hongting Zhao et al. · Frontiers in Cellular Neuroscience · 44 citations

10.3389/fncel.2017.001192017-04-25

Clinical Trial

1 records
clinicaltrialsAutomated import

FRDA Investigator Initiated Study (IIS) With Elamipretide

To evaluate the safety, tolerability, and activity of Elamipretide in treating vision loss in Friedreich Ataxia (FRDA).

NCT051687742021-12-09

Preprint

1 records
openalexAutomated import

Molecular Mechanism of Action of Mitochondrial Therapeutic SS-31 (Elamipretide): Membrane Interactions and Effects on Surface Electrostatics

Wayne A. Mitchell, Emily A. Ng, Jeffrey D. Tamucci, Kevin J. Boyd, Murugappan Sathappa, Adrian Coscia et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7 citations

10.1101/7350012019-08-14
Responsible use of information

Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.